(Q38014940)

English

Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems

scientific article published on June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

author name string

Georges Vauquelin

1

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Isabelle Van Liefde

2

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

language of work or name

0 references

publication date

1 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Expert Opinion on Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

583-595

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Kinetics of pharmacologic response

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Biochemical mechanisms of drug action: what does it take for success?

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001-2004: mechanisms leading to optimal efficacy and safety

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Drug-target residence time and its implications for lead optimization

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Residence time of receptor-ligand complexes and its effect on biological function

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Slow antagonist dissociation and long-lasting in vivo receptor protection

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Insulin interactions with its receptors: experimental evidence for negative cooperativity.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Insulin and its receptor: structure, function and evolution

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

G protein-coupled receptor allosterism and complexing

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

The best of both worlds? Bitopic orthosteric/allosteric ligands of g protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Physics of chemoreception

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Role of diffusion in ligand binding to macromolecules and cell-bound receptors

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Competition between solution and cell surface receptors for ligand. Dissociation of hapten bound to surface antibody in the presence of solution antibody

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Approximating the effects of diffusion on reversible reactions at the cell surface: ligand-receptor kinetics

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparations

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

On the significance of the retention of ligand by protein

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Diffusion delays and unstirred layer effects at monolayer cultures of Chinese hamster ovary cells: radioligand binding, confocal microscopy, and mathematical simulations.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Lipid rafts: bringing order to chaos

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Serial rebinding of ligands to clustered receptors as exemplified by bacterial chemotaxis

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Effects of receptor clustering on ligand dissociation kinetics: theory and simulations.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Effects of the geometry of the immunological synapse on the delivery of effector molecules.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

[3H]diprenorphine receptor binding in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterol

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

THRX-198321 is a bifunctional muscarinic receptor antagonist and beta2-adrenoceptor agonist (MABA) that binds in a bimodal and multivalent manner.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

New protein engineering approaches to multivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Structural basis of allosteric ligand-receptor interactions in the insulin/relaxin peptide family: implications for other receptor tyrosine kinases and G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

The insulin receptor: a prototype for dimeric, allosteric membrane receptors?

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Antagonist-radioligand binding to D2L-receptors in intact cells

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Mechanism of insulin and IGF-I receptor activation and signal transduction specificity. Receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Structure of the insulin receptor ectodomain reveals a folded-over conformation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Conformational adaptation in drug-target interactions and residence time

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Negative cooperativity in the human bradykinin B2 receptor.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Allosteric properties of G protein-coupled receptor oligomers

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Cooperative binding of insulin-like Peptide 3 to a dimeric relaxin family peptide receptor 2.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Ligand-selective receptor conformations revisited: the promise and the problem

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Ligand binding and micro-switches in 7TM receptor structures

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Fractal reaction kinetics

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Theoretical Analysis of Protein Concentration Determination Using Biosensor Technology under Conditions of Partial Mass Transport Limitation

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Cellular assays as portals to seven-transmembrane receptor-based drug discovery

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Ligands, their receptors and ... plasma membranes

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Contribution of dead-space microdomains to tortuosity of brain extracellular space

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

The heterogeneous course of drug transit through the body.

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2012.687720

21 January 2018

Identifiers

10.1517/17460441.2012.687720

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38014940&oldid=1737505034"